Deakin, named after Australia’s second Prime Minister, is a young contemporary university with a reputation for being innovative, nimble and friendly. We aspire every day to combine excellent research and outstanding teaching with a strong focus on the communities we serve. Deakin is ranked in the top 2 per cent of the world’s universities in each of the major rankings and ranking 211 in the Academic Ranking of World Universities (ARWU). Deakin researchers are making a difference through world-class research and innovation. Deakin has a strong sense of community and serves as an economic, social and cultural catalyst enriching each of the communities it serves.
Integrated DNA Technologies, Inc. (IDT) develops, manufactures and markets nucleic acid products for the life sciences industry in the fields of academic and commercial research, agriculture, medical diagnostics and drug development. IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, qPCR and RNA interference. Through its GMP services, IDT produces products for diagnostic testing of a variety of cancers and most genetic and infectious diseases. Serving more than 100,000 life sciences researchers, IDT produces more than 65,000 nucleic acids per day and is widely recognized as an industry leader in custom nucleic acid production. IDT’s manufacturing headquarters are located in Coralville, Iowa, USA, with additional manufacturing facilities in San Diego, California. Leuven, Belgium; and Singapore.
QIMR Berghofer Medical Research Institute is a world-leading translational research institute where research develops from the laboratory bench through to the patient’s bedside and is one of Australia’s largest and most successful institutes.
For over 70 years, QIMR Berghofer has led advances in the understanding, prevention, control, diagnosis and treatment of disease.
QIMR Berghofer focuses on cancer, infectious diseases, chronic disorders and mental health, and has developed impressive capability in genomics across these programs.